Regulating Tumor Myeloid-Derived Suppressor Cells by MicroRNAs

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Myeloid-derived suppressor cells (MDSCs) are critical mediators of tumor immune evasion.
• Understanding MDSC regulatory mechanisms is key to developing novel cancer immunotherapies.
• MicroRNAs (miRNAs) are emerging as significant regulators of immune cell function.

Purpose of the Study:

• To review the current literature on the role of specific miRNAs in regulating MDSCs.
• To highlight the impact of miRNAs on MDSC accumulation and function in cancer.
• To identify potential miRNA-based strategies for modulating anti-tumor immunity.

Main Methods:

• Comprehensive literature review of studies investigating miRNA-MDSC interactions.
• Analysis of data linking specific miRNAs to MDSC biology.
• Synthesis of findings on eight key miRNAs: miR-17-5p, miR-20a, miR-223, miR-21, miR-155, miR-494, miR-690, and miR-101.

Main Results:

• Evidence supports the involvement of eight specific miRNAs in modulating MDSC activity.
• These miRNAs influence both the expansion and suppressive functions of MDSCs.
• Dysregulation of these miRNAs is frequently observed in various cancer types.

Conclusions:

• Specific miRNAs play a crucial role in the regulation of myeloid-derived suppressor cells.
• Targeting these miRNAs presents a promising avenue for overcoming cancer immune suppression.
• Further research into miRNA-MDSC interactions could lead to innovative cancer treatments.